ARTICLE SUMMARY:
Market Pathways' editors highlight the major medtech policy issues and developments they'll be tracking in 2024; Leaders of the public-private Medical Device Innovation Consortium discuss their current efforts to identify and address barriers to innovation throughout the medical device life cycle; and in Consultants Corner, Marina Daineko discusses the finer points involved in building risk-based biocompatibility plans.
